pHLOGISTIX

pHLOGISTIX

While athletes are battling it out on a football, soccer or other athletic field, head injuries are stealing the headlines. Effective diagnosis of concussions is limited to observing symptoms typical of head trauma. But now, pHLOGISTIX has a blood test for concussions in development for point-of-injury diagnosis.

Repetitive concussions can lead to dementia and other neurological conditions if untreated.  Given the remarkable explosion in youth participation in contact sports, concussive rates in girls are exceeding those of boys.  

“Sandbox money will allow us to integrate the analyte and clinimetric data in order to have proof-of-concept,” says Barry Festoff, M.D., founder and CEO of pHLOGISTIX. “This can significantly change the way concussion and mild traumatic brain injury are diagnosed and treated. Current methods are all subjective.”

“As a father with a son playing football, anything we can do to better recognize and diagnose concussions is an important advancement,” says Shackelford, noting that no other solution like this exists. “pHLOGISTIX’s platform includes a digital component and software allowing for point-of-injury diagnostics that are objective.”